Login / Signup

The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors.

Paolo AlimontiL Nicolas Gonzalez Castro
Published in: Antibodies (Basel, Switzerland) (2023)
Antibodies against immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple aggressive malignancies, including melanoma and non-small cell lung cancer. ICIs for the treatment of primary and metastatic brain tumors have been used with varying degrees of success. Here, we discuss the available evidence for the use of ICIs in the treatment of primary and metastatic brain tumors, highlighting challenges and opportunities for furthering this type of cancer immunotherapy in neuro-oncology.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • palliative care
  • smoking cessation